Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sector movers: M&A gives pharma stocks a big boost

Tue, 22nd Apr 2014 15:28

Pharmaceuticals and biotechnology stocks were rising by an average of six per cent in London on Tuesday, helped by a wave of high-profile M&A deals across the global healthcare sector.Leading the charge in the UK was AstraZeneca on reports that it could be at the centre of the largest deal in pharmaceutical history.Shares were up 7% in afternoon trade after The Sunday Times said that Pfizer could make a takeover approach valuing the group at £60bn. This is a 25% premium to the recent share price and would represent the largest foreign takeover of a UK business on record.While Astra is reported to have rejected an initial offer, analysts at Citigroup said Pfizer is likely to "push aggressively ahead with a second approach".Meanwhile, GlaxoSmithKline (GSK) jumped after announcing a massive three-part deal with Swiss pharmaceuticals peer Novartis, which will see shareholders receive a £4bn capital return.Under the proposed transaction GSK and Novartis are to create a new consumer healthcare business, GSK will acquire Novartis's vaccines business for $5.25bn, and Novartis will buy GSK's oncology portfolio for $16bn.Meanwhile over in the States, Botox maker Allergan is subject to a $47bn takeover offer from Valeant Pharmaceuticals, and Eli Lilly announced that it would buy Novartis's animal health division for $5.4bn in cash.The increased M&A activity gave stocks across the sector a boost today, including Hikma, BTG and NMC Health.Shire was also making strong gains after Jefferies raised its target price for the group, saying that the recent share-price weakness has presented an "attractive buying opportunity". The broker lifted its target for the shares from 3,400p to 3,550p and kept a 'buy' rating.Jefferies actually trimmed its estimates for Shire slightly due to "sluggish" first-quarter ADHD prescriptions trends in the States, but said it still believes earnings will increase at a "robust" compound annual growth rate of 13% over 2013-2018. Top performing sectors so far todayPharmaceuticals & Biotechnology 12,439.17 +5.99%Industrial Metals & Mining 1,196.37 +4.13%Industrial Transportation 3,110.46 +2.36%Electronic & Electrical Equipment 4,269.48 +1.99%Food & Drug Retailers 3,840.40 +1.86%Bottom performing sectors so far todayBC
More News
12 Apr 2023 07:52

LONDON BRIEFING: Anglo American's De Beers shines; Unite bookings up

(Alliance News) - Stocks in London were called flat on Wednesday, with the focus for the day on a US inflation reading in the afternoon, before the release of central bank meeting minutes later.

Read more
12 Apr 2023 07:18

Hikma appoints Riad Mishlawi as CEO

(Sharecast News) - Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.

Read more
6 Apr 2023 09:20

LONDON BROKER RATINGS: Goldman raises Spirent to 'neutral' from 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
16 Mar 2023 15:50

UK dividends calendar - next 7 days

Friday 17 March 
JPMorgan Claverhouse Investment Trust PLCdividend payment date
Knights Group Holdings PLCdividend payment date
NCC Group PLCdividend payment date
Pershing Square Holdings Ltddividend payment date
Ruffer Investment Co Ltddividend payment date
Witan Investment Trust PLCdividend payment date
Monday 20 March 
Aquila Energy Efficiency Trust PLCdividend payment date
Essentra PLCspecial ex-dividend payment date  
Shaftesbury Capital PLCdividend payment date
Tuesday 21 March 
abrdn Asia Focus PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
Unilever PLCdividend payment date
Wednesday 22 March 
abrdn Equity Income Trust PLCdividend payment date
Thursday 23 March 
BlackRock Energy & Resources Income Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
Close Brothers Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Craneware PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Glanbia PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Hipgnosis Songs Fund Ltdex-dividend payment date
Jersey Electricity PLCdividend payment date
Nichols PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Prudential PLCex-dividend payment date
Schroders PLCex-dividend payment date
Securities Trust of Scotland PLCex-dividend payment date
Volution Group PLCex-dividend payment date
XP Power Ltdex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
13 Mar 2023 09:40

LONDON BROKER RATINGS: JPMorgan cuts BAT; raises Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Mar 2023 09:15

LONDON BROKER RATINGS: Liberum cuts National Express to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.